Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ludwig Enterprises Inc (OP:LUDG)

0.1250 +0.0150 (+13.64%)
Streaming Delayed Price Updated: 9:30 AM EDT, May 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,050
Open 0.1250
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1100
Today's Range 0.1250 - 0.1250
52wk Range 0.0800 - 0.3949
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology
Via ACCESS Newswire
Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.
Via ACCESS Newswire

Performance

YTD
-26.5%
-26.5%
1 Month
-10.1%
-10.1%
3 Month
-20.4%
-20.4%
6 Month
-21.9%
-21.9%
1 Year
-38.0%
-38.0%

More News

Read More
Ludwig Enterprises Begins PCR Validation Test Process
Via ACCESSWIRE
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
Via ACCESSWIRE
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
Via ACCESSWIRE
Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
Via ACCESSWIRE
Ludwig Announces Substantial Corporate Initiatives
Via ACCESSWIRE
Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D. as Chief Executive Officer
Via ACCESSWIRE
LUDG Files Genomic Patent AI Uncovers Differentially Expressed Genes
Via ACCESSWIRE
Ludwig Announces Acquisition of Intellectual Property and Patent
Via ACCESSWIRE
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
Via ACCESSWIRE
Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study
Via ACCESSWIRE
Ludwig Enterprises mRNA Bladder Cancer Study to be Launched
Via ACCESSWIRE
Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program
Via ACCESSWIRE
Ludwig Enterprises Appoints Scott Silverman as CFO
Via ACCESSWIRE
Ludwig Enterprises Announces Effectiveness of Form S-1 Registration Application, Becomes an SEC Reporting Company
Via ACCESSWIRE
Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market
Via ACCESSWIRE
Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan
Via ACCESSWIRE
Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation
Via ACCESSWIRE
Decoding mRNA for Early Disease Detection, Treatment & Prevention
Via ACCESSWIRE
Ludwig Enterprises Announces Agreement with Summit Bancorp to Assist with Cross Listing on the Canadian Stock Exchange
Via ACCESSWIRE
Ludwig Enterprises Announces Intention to List on the Canadian Stock Exchange
Via ACCESSWIRE
Ludwig Enterprises Developing New Partnerships to Fuel Growth
Via ACCESSWIRE
Ludwig Enterprise mRNA Program Generating Broad Clinical Interest
Via ACCESSWIRE
Ludwig Enterprises Announces Brand Name for Groundbreaking Nutraceutical
Via ACCESSWIRE

Frequently Asked Questions

Is Ludwig Enterprises Inc publicly traded?
Yes, Ludwig Enterprises Inc is publicly traded.
What exchange does Ludwig Enterprises Inc trade on?
Ludwig Enterprises Inc trades on the OTC Traded
What is the ticker symbol for Ludwig Enterprises Inc?
The ticker symbol for Ludwig Enterprises Inc is LUDG on the OTC Traded
What is the current price of Ludwig Enterprises Inc?
The current price of Ludwig Enterprises Inc is 0.1250
When was Ludwig Enterprises Inc last traded?
The last trade of Ludwig Enterprises Inc was at 05/06/25 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.